SELECT MED HLDGS CORP's ticker is SEM and the CUSIP is 81619Q105. A total of 199 filers reported holding SELECT MED HLDGS CORP in Q3 2020. The put-call ratio across all filers is 1.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,036,002 | +4.5% | 278,433 | +31.8% | 0.44% | +6.3% |
Q2 2023 | $6,731,253 | +41.5% | 211,276 | +14.8% | 0.41% | +37.3% |
Q1 2023 | $4,756,141 | +109539.0% | 183,990 | +5.3% | 0.30% | +25.5% |
Q4 2022 | $4,338 | -99.9% | 174,724 | +14.4% | 0.24% | +12.2% |
Q3 2022 | $3,375,000 | +7.5% | 152,737 | +14.9% | 0.21% | +12.7% |
Q2 2022 | $3,140,000 | +10.5% | 132,941 | +12.3% | 0.19% | +30.3% |
Q1 2022 | $2,841,000 | -74.4% | 118,408 | -68.6% | 0.14% | -63.1% |
Q4 2021 | $11,085,000 | -25.3% | 377,037 | -8.1% | 0.39% | -26.3% |
Q3 2021 | $14,839,000 | +6.9% | 410,250 | +24.9% | 0.53% | +12.2% |
Q2 2021 | $13,882,000 | -8.1% | 328,490 | -25.8% | 0.48% | -4.4% |
Q1 2021 | $15,106,000 | -5.7% | 442,987 | -23.5% | 0.50% | -20.9% |
Q4 2020 | $16,016,000 | +33.4% | 579,034 | +0.4% | 0.63% | +8.3% |
Q3 2020 | $12,002,000 | +39.7% | 576,449 | -1.1% | 0.58% | +38.4% |
Q2 2020 | $8,589,000 | +3.5% | 583,094 | +5.4% | 0.42% | -10.5% |
Q1 2020 | $8,300,000 | -22.9% | 553,346 | +19.9% | 0.47% | +15.3% |
Q4 2019 | $10,772,000 | -15.6% | 461,534 | -40.1% | 0.41% | -22.8% |
Q3 2019 | $12,760,000 | +16.8% | 770,072 | +11.8% | 0.53% | +22.3% |
Q2 2019 | $10,927,000 | +25.0% | 688,511 | +11.0% | 0.43% | +22.5% |
Q1 2019 | $8,742,000 | -51.4% | 620,449 | -42.1% | 0.35% | -5.1% |
Q4 2018 | $17,980,000 | +94.6% | 1,071,504 | +113.4% | 0.37% | +5.4% |
Q3 2018 | $9,240,000 | -34.9% | 502,147 | -35.8% | 0.35% | -39.5% |
Q2 2018 | $14,188,000 | +15.4% | 781,719 | +9.7% | 0.58% | +10.9% |
Q1 2018 | $12,297,000 | +4.2% | 712,861 | +6.6% | 0.52% | +6.5% |
Q4 2017 | $11,803,000 | -5.1% | 668,723 | +3.3% | 0.49% | -1.0% |
Q3 2017 | $12,431,000 | +3.3% | 647,430 | -17.4% | 0.50% | +0.4% |
Q2 2017 | $12,034,000 | +19.7% | 783,969 | +4.1% | 0.49% | +17.6% |
Q1 2017 | $10,056,000 | +14.7% | 753,278 | +13.9% | 0.42% | +11.1% |
Q4 2016 | $8,766,000 | -27.3% | 661,569 | -25.9% | 0.38% | -40.5% |
Q3 2016 | $12,061,000 | +29.2% | 893,374 | +4.0% | 0.64% | +19.8% |
Q2 2016 | $9,338,000 | – | 859,075 | – | 0.53% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hillcrest Asset Management LLC | 455,999 | $13,406,000 | 2.04% |
Smith, Graham & Co., Investment Advisors, LP | 445,634 | $13,102,000 | 1.30% |
DENALI ADVISORS LLC | 118,200 | $3,475,000 | 1.30% |
Huber Capital Management LLC | 155,484 | $4,571,000 | 1.20% |
Sivik Global Healthcare LLC | 90,000 | $2,646,000 | 1.13% |
Hood River Capital Management LLC | 1,163,403 | $34,204,000 | 1.02% |
Phocas Financial Corp. | 234,059 | $6,881,000 | 0.88% |
BOULDER HILL CAPITAL MANAGEMENT LP | 18,600 | $547,000 | 0.53% |
Orbimed Advisors | 1,233,600 | $36,268,000 | 0.47% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,385,402 | $70,131,000 | 0.41% |